The screening of compound arrays in in vitro bioassays has developed into a
powerful tool for the identification of biologically active substances. In
the past decade, this technology has increasingly been applied to immunolo
gy. As the specificity of the immune system is determined by antigen detect
ion via receptors on B and T cells, targeting the specificity of these immu
ne receptors with random arrays is unique in its ability to generate genera
l and quantitative information on cellular (cross-)reactivity. Synthetic ar
ray studies have been useful for identification of epitopes and antigens fr
om databases by defining recognition patterns, isolation of synthetic pepti
des capable of modulating T cell responsiveness, characterisation of TCR pr
omiscuity, and identification of functionally cross-reacting peptides that
are potentially involved in molecular mimicry.